関節炎治療薬の世界市場レポート 2025年

関節炎治療薬市場規模は、今後数年間で力強い成長が見込まれます。2029年にはCAGR6.1％で917億2,000万米ドルに成長します。予測期間の成長は、ヘルスケアインフラの改善、政府のイニシアティブ、支持的な規制の枠組み、個別化医療の重視、患者中心のヘルスケアアプローチへのシフトに起因しています。予測期間における主な動向としては、バイオシミラーへの注目、生物製剤へのパラダイムシフト、バイオシミラーの利用可能性の向上、非経口経路の選好、オンライン薬局の成長などが挙げられます。

関節炎の罹患率の上昇が関節炎治療薬市場の成長を牽引すると予想されます。関節炎は、主に関節の痛みや炎症を特徴とする100以上の疾患を包含します。関節炎の有病率の増加は、高齢化、肥満率の上昇、関節ストレスや炎症の原因となるライフスタイル要因に起因しています。関節炎の治療は、症状を和らげ、炎症を抑え、関節機能を改善することで、罹患者の全体的な生活の質を向上させます。例えば、オーストラリアに本部を置く政府機関Australian Institute of Health and Welfareが2024年6月に発表した報告書によると、2022年には約51万4,000人（人口の2.0％）が関節リウマチに罹患しているといいます。関節リウマチは全疾患負担の2.0%を占め、2023年には全筋骨格系疾患の負担の16%を占める。このように、関節炎の罹患率の増加が関節炎治療薬市場の拡大に拍車をかけています。

関節炎治療市場の主要企業は、バイオシミラーモノクローナル抗体ベースの治療薬など、治療効果の向上とコスト削減を目的とした先進的ソリューションの開発に注力しています。これらの治療薬は、オリジナルのモノクローナル抗体の効果を忠実に再現するように設計されており、同様の治療効果を潜在的な低コストで提供します。例えば、2024年5月、中国のバイオ医薬品会社Bio-Thera Solutions Ltd.は、ACTEMRAをベースとしたバイオシミラーモノクローナル抗体の静脈内投与製剤であるTOFIDENCEを発表しました。TOFIDENCE（tocilizumab-bavi）は、基準薬ACTEMRAのバイオシミラーとして開発され、中等度から重度の活動性の関節リウマチ、多関節型若年性特発性関節炎、全身型若年性特発性関節炎の治療薬として承認されています。

目次

第1章 エグゼクティブサマリー

第2章 市場の特徴

第3章 市場動向と戦略

第4章 市場- 金利、インフレ、地政学、新型コロナウイルス感染症、そして景気回復が市場に与える影響を含むマクロ経済シナリオ

第5章 世界の成長分析と戦略分析フレームワーク

• 世界関節炎治療薬PESTEL分析（政治、社会、技術、環境、法的要因、促進要因と抑制要因）
• 最終用途産業の分析
• 世界の関節炎治療薬市場：成長率分析
• 世界の関節炎治療薬市場の実績：規模と成長, 2019-2024
• 世界の関節炎治療薬市場の予測：規模と成長, 2024-2029, 2034F
• 世界関節炎治療薬総アドレス可能市場（TAM）

第6章 市場セグメンテーション

• 世界の関節炎治療薬市場薬剤クラス別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 腫瘍壊死因子（TNF）阻害剤
• インターロイキン阻害剤
• 非ステロイド性抗炎症薬（NSAID）
• コルチコステロイド
• キサンチンオキシダーゼ阻害剤
• その他の薬物クラス
• 世界の関節炎治療薬市場：投与経路別、実績と予測, 2019-2024, 2024-2029F, 2034F
• オーラル
• 非経口
• トピック
• 世界の関節炎治療薬市場：タイプ別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 乾癬性関節炎
• 関節リウマチ
• 変形性関節症
• 痛風
• その他のタイプ
• 世界の関節炎治療薬市場：流通チャネル別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 病院薬局
• 小売薬局
• オンライン薬局
• 世界の関節炎治療薬市場腫瘍壊死因子（TNF）阻害剤の種類別サブセグメンテーション、実績と予測, 2019-2024, 2024-2029F, 2034F
• アダリムマブ
• エタネルセプト
• インフリキシマブ
• セルトリズマブペゴル
• ゴリムマブ
• 世界の関節炎治療薬市場インターロイキン阻害剤の種類別サブセグメンテーション、実績と予測, 2019-2024, 2024-2029F, 2034F
• インターロイキン-6（IL-6）阻害剤
• インターロイキン-1（IL-1）阻害剤
• インターロイキン-17（IL-17）阻害剤
• インターロイキン-23（IL-23）阻害剤
• 世界の関節炎治療薬市場非ステロイド性抗炎症薬（NSAIDs）の種類別サブセグメンテーション、実績と予測, 2019-2024, 2024-2029F, 2034F
• イブプロフェン
• ナプロキセン
• ジクロフェナク
• セレコキシブ
• メロキシカム
• 世界の関節炎治療薬市場コルチコステロイドの種類別サブセグメンテーション、実績と予測, 2019-2024, 2024-2029F, 2034F
• プレドニゾン
• メチルプレドニゾロン
• ヒドロコルチゾン
• デキサメタゾン
• 世界の関節炎治療薬市場キサンチンオキシダーゼ阻害剤の種類別サブセグメンテーション、実績と予測, 2019-2024, 2024-2029F, 2034F
• アロプリノール
• フェブキソスタット
• 世界の関節炎治療薬市場、その他の薬物クラスのタイプ別サブセグメンテーション、実績と予測, 2019-2024, 2024-2029F, 2034F
• 疾患修飾抗リウマチ薬（DMARD）
• ヤヌスキナーゼ（JAK）阻害剤
• 生物学的DMARD
• 局所鎮痛剤
• オピオイド鎮痛薬

第7章 地域別・国別分析

• 世界の関節炎治療薬市場：地域別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 世界の関節炎治療薬市場：国別、実績と予測, 2019-2024, 2024-2029F, 2034F

第8章 アジア太平洋市場

第9章 中国市場

第10章 インド市場

第11章 日本市場

第12章 オーストラリア市場

第13章 インドネシア市場

第14章 韓国市場

第15章 西欧市場

第16章 英国市場

第17章 ドイツ市場

第18章 フランス市場

第19章 イタリア市場

第20章 スペイン市場

第21章 東欧市場

第22章 ロシア市場

第23章 北米市場

第24章 米国市場

第25章 カナダ市場

第26章 南米市場

第27章 ブラジル市場

第28章 中東市場

第29章 アフリカ市場

第30章 競合情勢と企業プロファイル

• 関節炎治療薬市場：競合情勢
• 関節炎治療薬市場：企業プロファイル
  • Pfizer Inc. Overview, Products and Services, Strategy and Financial Analysis
  • Johnson & Johnson Overview, Products and Services, Strategy and Financial Analysis
  • Hoffmann-La Roche Ltd Overview, Products and Services, Strategy and Financial Analysis
  • Merck & Co. Inc. Overview, Products and Services, Strategy and Financial Analysis
  • AbbVie Inc. Overview, Products and Services, Strategy and Financial Analysis

第31章 その他の大手企業と革新的企業

• Sanofi S.A.
• Bristol-Myers Squibb Company
• AstraZeneca Pharma AB
• GlaxoSmithKline plc
• Eli Lilly and Company
• Amgen Inc.
• Gilead Sciences Inc.
• Regeneron Pharmaceuticals Inc.
• Astellas Pharma Inc.
• Biogen Inc.
• Vertex Pharmaceuticals Incorporated
• Zimmer Biomet Holdings Inc.
• UCB Pharma S.A.
• Incyte Corporation
• Celltrion Inc.

第32章 世界の市場競合ベンチマーキングとダッシュボード

第33章 主要な合併と買収

第34章 最近の市場動向

第35章 市場の潜在力が高い国、セグメント、戦略

• 関節炎治療薬市場2029：新たな機会を提供する国
• 関節炎治療薬市場2029：新たな機会を提供するセグメント
• 関節炎治療薬市場2029：成長戦略
  • 市場動向に基づく戦略
  • 競合の戦略

第36章 付録

Arthritic therapeutics are treatments aimed at relieving symptoms and improving the quality of life for individuals with arthritis. These therapies include medications, physical therapy, and other interventions designed to reduce pain, inflammation, and joint damage, helping to manage conditions such as osteoarthritis and rheumatoid arthritis.

Key drug classes used in arthritic therapeutics include tumor necrosis factor (TNF) inhibitors, interleukin inhibitors, nonsteroidal anti-inflammatory drugs (NSAIDs), corticosteroids, xanthine oxidase inhibitors, and others. TNF inhibitors work by blocking TNF, a protein involved in inflammation, to treat autoimmune diseases. They can be administered orally, parenterally, or topically and are used for various types of arthritis, including psoriatic arthritis, rheumatoid arthritis, osteoarthritis, and gout. These drugs are available through multiple distribution channels, such as hospital pharmacies, retail pharmacies, and online pharmacies.

The arthritic therapeutic market research report is one of a series of new reports from The Business Research Company that provides arthritic therapeutic market statistics, including the arthritic therapeutic industry's global market size, regional shares, competitors with a arthritic therapeutic market share, detailed arthritic therapeutic market segments, market trends and opportunities, and any further data you may need to thrive in the arthritic therapeutic industry. This arthritic therapeutic market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenarios of the industry.

The arthritic therapeutic market size has grown strongly in recent years. It will grow from $68.1 $ billion in 2024 to $72.44 $ billion in 2025 at a compound annual growth rate (CAGR) of 6.4%. The growth in the historic period can be attributed to increasing number of diagnosed patients, increasing awareness about the symptoms, increasing prevalence of obesity, improved diagnostic skills, and improved treatment outcomes.

The arthritic therapeutic market size is expected to see strong growth in the next few years. It will grow to $91.72 $ billion in 2029 at a compound annual growth rate (CAGR) of 6.1%. The growth in the forecast period can be attributed to improving healthcare infrastructure, government initiatives, supportive regulatory frameworks, focus on personalized medicine, and shift towards patient-centric healthcare approaches. Major trends in the forecast period include focus on biosimilar, shifting paradigm towards biologics, enhanced availability of biosimilars, preference for parenteral route, and growth of online pharmacies.

The rising incidence of arthritis is expected to drive the growth of the arthritic therapeutic market. Arthritis encompasses over 100 conditions primarily characterized by joint pain and inflammation. The increasing prevalence of arthritis is attributed to an aging population, rising obesity rates, and lifestyle factors that contribute to joint stress and inflammation. Treatments for arthritis help relieve symptoms, reduce inflammation, and improve joint function, thus enhancing the overall quality of life for those affected. For example, a June 2024 report from the Australian Institute of Health and Welfare, a government organization based in Australia, noted that approximately 514,000 people (2.0% of the population) were living with rheumatoid arthritis in 2022. Rheumatoid arthritis accounted for 2.0% of the total disease burden and represented 16% of the total burden for all musculoskeletal conditions in 2023. Thus, the growing incidence of arthritis is fueling the expansion of the arthritic therapeutic market.

Leading companies in the arthritis therapeutic market are concentrating on developing advanced solutions, such as biosimilar monoclonal antibody-based therapies, to improve treatment efficacy and reduce costs. These therapies are designed to closely replicate the effectiveness of original monoclonal antibodies, offering similar therapeutic benefits at potentially lower costs. For instance, in May 2024, Bio-Thera Solutions Ltd., a biopharmaceutical company based in China, introduced TOFIDENCE, an intravenous biosimilar monoclonal antibody formulation based on ACTEMRA. TOFIDENCE (tocilizumab-bavi) is developed as a biosimilar to the reference drug ACTEMRA and is approved for treating moderately to severely active rheumatoid arthritis, polyarticular juvenile idiopathic arthritis, and systemic juvenile idiopathic arthritis.

In October 2023, Amgen Inc., a biotechnology company based in the US, acquired Horizon Therapeutics Plc for $27.8 billion. This acquisition aims to strengthen Amgen's portfolio of innovative medicines for rare diseases, leveraging Horizon Therapeutics' capabilities to reach more patients globally and drive long-term growth. Horizon Therapeutics plc is an Ireland-based biotechnology company specializing in arthritic therapies.

Major companies operating in the arthritic therapeutic market are Pfizer Inc., Johnson & Johnson, Hoffmann-La Roche Ltd, Merck & Co Inc., AbbVie Inc., Sanofi S.A., Bristol-Myers Squibb Company, AstraZeneca Pharma AB, GlaxoSmithKline plc, Eli Lilly and Company, Amgen Inc., Gilead Sciences Inc., Regeneron Pharmaceuticals Inc., Astellas Pharma Inc., Biogen Inc., Vertex Pharmaceuticals Incorporated, Zimmer Biomet Holdings Inc., UCB Pharma S.A., Incyte Corporation, Celltrion Inc., Mallinckrodt Pharmaceuticals, Genentech Inc., Anika Therapeutics Inc., Medac GmbH

North America was the largest region in the arthritic therapeutic market in 2023. The regions covered in the arthritic therapeutic market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the arthritic therapeutic market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The arthritic therapeutics market consists of revenues earned by entities by providing services such as physical therapy services, occupational therapy, diagnostic services, and wellness programs. The market value includes the value of related goods sold by the service provider or included within the service offering. The arthritic therapeutics market also includes sales of analgesics, joint injections, supplements, and disease-modifying antirheumatic drugs (DMARDs). Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Arthritic Therapeutic Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on arthritic therapeutic market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

• Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
• Assess the impact of key macro factors such as conflict, pandemic and recovery, inflation and interest rate environment and the 2nd Trump presidency.
• Create regional and country strategies on the basis of local data and analysis.
• Identify growth segments for investment.
• Outperform competitors using forecast data and the drivers and trends shaping the market.
• Understand customers based on the latest market shares.
• Benchmark performance against key competitors.
• Suitable for supporting your internal and external presentations with reliable high quality data and analysis
• Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
• All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for arthritic therapeutic ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The arthritic therapeutic market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

• The market characteristics section of the report defines and explains the market.
• The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
• The forecasts are made after considering the major factors currently impacting the market. These include:

The forecasts are made after considering the major factors currently impacting the market. These include the Russia-Ukraine war, rising inflation, higher interest rates, and the legacy of the COVID-19 pandemic.

• Market segmentations break down the market into sub markets.
• The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
• The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
• The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

• Markets Covered:1) By Drug Class: Tumor Necrosis Factor (TNF) Inhibitors; Interleukin Inhibitors; Nonsteroidal Anti-Inflammatory Drugs (NSAIDs); Corticosteroids; Xanthine Oxidase Inhibitors; Other Drug Classes
• 2) By Route Of Administration: Oral; Parenteral; Topical
• 3) By Type: Psoriatic Arthritis; Rheumatoid Arthritis; Osteoarthritis; Gout; Other Types
• 4) By Distribution Channel: Hospital Pharmacies; Retail Pharmacies; Online Pharmacies
• Subsegments:
• 1) By Tumor Necrosis Factor (TNF) Inhibitors: Adalimumab; Etanercept; Infliximab; Certolizumab Pegol; Golimumab
• 2) By Interleukin Inhibitors: Interleukin-6 (IL-6) Inhibitors; Interleukin-1 (IL-1) Inhibitors; Interleukin-17 (IL-17) Inhibitors; Interleukin-23 (IL-23) Inhibitors
• 3) By Nonsteroidal Anti-Inflammatory Drugs (NSAIDs): Ibuprofen; Naproxen; Diclofenac; Celecoxib; Meloxicam
• 4) By Corticosteroids: Prednisone; Methylprednisolone; Hydrocortisone; Dexamethasone
• 5) By Xanthine Oxidase Inhibitors: Allopurinol; Febuxostat
• 6) By Other Drug Classes: Disease-Modifying Antirheumatic Drugs (DMARDs); Janus Kinase (JAK) Inhibitors; Biologic DMARDs; Topical Analgesics; Opioid Pain Medications
• Companies Mentioned: Pfizer Inc.; Johnson & Johnson; Hoffmann-La Roche Ltd; Merck & Co Inc.; AbbVie Inc.
• Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
• Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
• Time series: Five years historic and ten years forecast.
• Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
• Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
• Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
• Delivery format: PDF, Word and Excel Data Dashboard.

Table of Contents

1. Executive Summary

2. Arthritic Therapeutic Market Characteristics

3. Arthritic Therapeutic Market Trends And Strategies

4. Arthritic Therapeutic Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Covid And Recovery On The Market

5. Global Arthritic Therapeutic Growth Analysis And Strategic Analysis Framework

• 5.1. Global Arthritic Therapeutic PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
• 5.2. Analysis Of End Use Industries
• 5.3. Global Arthritic Therapeutic Market Growth Rate Analysis
• 5.4. Global Arthritic Therapeutic Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
• 5.5. Global Arthritic Therapeutic Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
• 5.6. Global Arthritic Therapeutic Total Addressable Market (TAM)

6. Arthritic Therapeutic Market Segmentation

• 6.1. Global Arthritic Therapeutic Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Tumor Necrosis Factor (TNF) Inhibitors
• Interleukin Inhibitors
• Nonsteroidal Anti-Inflammatory Drugs (NSAIDs)
• Corticosteroids
• Xanthine Oxidase Inhibitors
• Other Drug Classes
• 6.2. Global Arthritic Therapeutic Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Oral
• Parenteral
• Topical
• 6.3. Global Arthritic Therapeutic Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Psoriatic Arthritis
• Rheumatoid Arthritis
• Osteoarthritis
• Gout
• Other Types
• 6.4. Global Arthritic Therapeutic Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Hospital Pharmacies
• Retail Pharmacies
• Online Pharmacies
• 6.5. Global Arthritic Therapeutic Market, Sub-Segmentation Of Tumor Necrosis Factor (TNF) Inhibitors, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Adalimumab
• Etanercept
• Infliximab
• Certolizumab Pegol
• Golimumab
• 6.6. Global Arthritic Therapeutic Market, Sub-Segmentation Of Interleukin Inhibitors, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Interleukin-6 (IL-6) Inhibitors
• Interleukin-1 (IL-1) Inhibitors
• Interleukin-17 (IL-17) Inhibitors
• Interleukin-23 (IL-23) Inhibitors
• 6.7. Global Arthritic Therapeutic Market, Sub-Segmentation Of Nonsteroidal Anti-Inflammatory Drugs (NSAIDs), By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Ibuprofen
• Naproxen
• Diclofenac
• Celecoxib
• Meloxicam
• 6.8. Global Arthritic Therapeutic Market, Sub-Segmentation Of Corticosteroids, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Prednisone
• Methylprednisolone
• Hydrocortisone
• Dexamethasone
• 6.9. Global Arthritic Therapeutic Market, Sub-Segmentation Of Xanthine Oxidase Inhibitors, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Allopurinol
• Febuxostat
• 6.10. Global Arthritic Therapeutic Market, Sub-Segmentation Of Other Drug Classes, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Disease-Modifying Antirheumatic Drugs (DMARDs)
• Janus Kinase (JAK) Inhibitors
• Biologic DMARDs
• Topical Analgesics
• Opioid Pain Medications

7. Arthritic Therapeutic Market Regional And Country Analysis

• 7.1. Global Arthritic Therapeutic Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 7.2. Global Arthritic Therapeutic Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific Arthritic Therapeutic Market

• 8.1. Asia-Pacific Arthritic Therapeutic Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 8.2. Asia-Pacific Arthritic Therapeutic Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 8.3. Asia-Pacific Arthritic Therapeutic Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 8.4. Asia-Pacific Arthritic Therapeutic Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China Arthritic Therapeutic Market

• 9.1. China Arthritic Therapeutic Market Overview
• 9.2. China Arthritic Therapeutic Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
• 9.3. China Arthritic Therapeutic Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
• 9.4. China Arthritic Therapeutic Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India Arthritic Therapeutic Market

• 10.1. India Arthritic Therapeutic Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 10.2. India Arthritic Therapeutic Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 10.3. India Arthritic Therapeutic Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan Arthritic Therapeutic Market

• 11.1. Japan Arthritic Therapeutic Market Overview
• 11.2. Japan Arthritic Therapeutic Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 11.3. Japan Arthritic Therapeutic Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 11.4. Japan Arthritic Therapeutic Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia Arthritic Therapeutic Market

• 12.1. Australia Arthritic Therapeutic Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 12.2. Australia Arthritic Therapeutic Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 12.3. Australia Arthritic Therapeutic Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia Arthritic Therapeutic Market

• 13.1. Indonesia Arthritic Therapeutic Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 13.2. Indonesia Arthritic Therapeutic Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 13.3. Indonesia Arthritic Therapeutic Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea Arthritic Therapeutic Market

• 14.1. South Korea Arthritic Therapeutic Market Overview
• 14.2. South Korea Arthritic Therapeutic Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 14.3. South Korea Arthritic Therapeutic Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 14.4. South Korea Arthritic Therapeutic Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe Arthritic Therapeutic Market

• 15.1. Western Europe Arthritic Therapeutic Market Overview
• 15.2. Western Europe Arthritic Therapeutic Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 15.3. Western Europe Arthritic Therapeutic Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 15.4. Western Europe Arthritic Therapeutic Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK Arthritic Therapeutic Market

• 16.1. UK Arthritic Therapeutic Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 16.2. UK Arthritic Therapeutic Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 16.3. UK Arthritic Therapeutic Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany Arthritic Therapeutic Market

• 17.1. Germany Arthritic Therapeutic Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 17.2. Germany Arthritic Therapeutic Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 17.3. Germany Arthritic Therapeutic Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France Arthritic Therapeutic Market

• 18.1. France Arthritic Therapeutic Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 18.2. France Arthritic Therapeutic Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 18.3. France Arthritic Therapeutic Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy Arthritic Therapeutic Market

• 19.1. Italy Arthritic Therapeutic Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 19.2. Italy Arthritic Therapeutic Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 19.3. Italy Arthritic Therapeutic Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain Arthritic Therapeutic Market

• 20.1. Spain Arthritic Therapeutic Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 20.2. Spain Arthritic Therapeutic Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 20.3. Spain Arthritic Therapeutic Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Arthritic Therapeutic Market

• 21.1. Eastern Europe Arthritic Therapeutic Market Overview
• 21.2. Eastern Europe Arthritic Therapeutic Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 21.3. Eastern Europe Arthritic Therapeutic Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 21.4. Eastern Europe Arthritic Therapeutic Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia Arthritic Therapeutic Market

• 22.1. Russia Arthritic Therapeutic Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 22.2. Russia Arthritic Therapeutic Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 22.3. Russia Arthritic Therapeutic Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America Arthritic Therapeutic Market

• 23.1. North America Arthritic Therapeutic Market Overview
• 23.2. North America Arthritic Therapeutic Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 23.3. North America Arthritic Therapeutic Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 23.4. North America Arthritic Therapeutic Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA Arthritic Therapeutic Market

• 24.1. USA Arthritic Therapeutic Market Overview
• 24.2. USA Arthritic Therapeutic Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 24.3. USA Arthritic Therapeutic Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 24.4. USA Arthritic Therapeutic Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada Arthritic Therapeutic Market

• 25.1. Canada Arthritic Therapeutic Market Overview
• 25.2. Canada Arthritic Therapeutic Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 25.3. Canada Arthritic Therapeutic Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 25.4. Canada Arthritic Therapeutic Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America Arthritic Therapeutic Market

• 26.1. South America Arthritic Therapeutic Market Overview
• 26.2. South America Arthritic Therapeutic Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 26.3. South America Arthritic Therapeutic Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 26.4. South America Arthritic Therapeutic Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil Arthritic Therapeutic Market

• 27.1. Brazil Arthritic Therapeutic Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 27.2. Brazil Arthritic Therapeutic Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 27.3. Brazil Arthritic Therapeutic Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East Arthritic Therapeutic Market

• 28.1. Middle East Arthritic Therapeutic Market Overview
• 28.2. Middle East Arthritic Therapeutic Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 28.3. Middle East Arthritic Therapeutic Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 28.4. Middle East Arthritic Therapeutic Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa Arthritic Therapeutic Market

• 29.1. Africa Arthritic Therapeutic Market Overview
• 29.2. Africa Arthritic Therapeutic Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 29.3. Africa Arthritic Therapeutic Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 29.4. Africa Arthritic Therapeutic Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. Arthritic Therapeutic Market Competitive Landscape And Company Profiles

• 30.1. Arthritic Therapeutic Market Competitive Landscape
• 30.2. Arthritic Therapeutic Market Company Profiles
  • 30.2.1. Pfizer Inc. Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.2. Johnson & Johnson Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.3. Hoffmann-La Roche Ltd Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.4. Merck & Co. Inc. Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.5. AbbVie Inc. Overview, Products and Services, Strategy and Financial Analysis

31. Arthritic Therapeutic Market Other Major And Innovative Companies

• 31.1. Sanofi S.A.
• 31.2. Bristol-Myers Squibb Company
• 31.3. AstraZeneca Pharma AB
• 31.4. GlaxoSmithKline plc
• 31.5. Eli Lilly and Company
• 31.6. Amgen Inc.
• 31.7. Gilead Sciences Inc.
• 31.8. Regeneron Pharmaceuticals Inc.
• 31.9. Astellas Pharma Inc.
• 31.10. Biogen Inc.
• 31.11. Vertex Pharmaceuticals Incorporated
• 31.12. Zimmer Biomet Holdings Inc.
• 31.13. UCB Pharma S.A.
• 31.14. Incyte Corporation
• 31.15. Celltrion Inc.

32. Global Arthritic Therapeutic Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Arthritic Therapeutic Market

34. Recent Developments In The Arthritic Therapeutic Market

35. Arthritic Therapeutic Market High Potential Countries, Segments and Strategies

• 35.1 Arthritic Therapeutic Market In 2029 - Countries Offering Most New Opportunities
• 35.2 Arthritic Therapeutic Market In 2029 - Segments Offering Most New Opportunities
• 35.3 Arthritic Therapeutic Market In 2029 - Growth Strategies
  • 35.3.1 Market Trend Based Strategies
  • 35.3.2 Competitor Strategies

36. Appendix

• 36.1. Abbreviations
• 36.2. Currencies
• 36.3. Historic And Forecast Inflation Rates
• 36.4. Research Inquiries
• 36.5. The Business Research Company
• 36.6. Copyright And Disclaimer